Long-term cancer survivors struggle to keep regular work hours

June 19, 2012

Long-term cancer survivors take sick leave more often than their disease-free colleagues, suggesting that they struggle at work despite their ability to work five years after diagnosis. These findings by Steffen Torp, from Vestfold University College in Norway, and colleagues is published online in Springer's Journal of Cancer Survivorship.

Most cancer survivors return to work. The ability to work following is important for maintaining self-respect, identity and living standard. For society, keeping people employed is key both for economic reasons and to prevent . Research to date shows that most cancer survivors are able to return to work, though a significant proportion report a reduced ability to work.

Torp and team observed the sick leave patterns of cancer survivors for five consecutive years after diagnosis. They were also interested in factors that might predict the amount of sick leave taken during the fifth year, including socio-demographic factors (education, family status, annual income, and occupation) and clinical factors ( and severity).

They analyzed data from Norwegian population-based registries and the Cancer Registry of Norway for 2,008 adults who had been diagnosed with . The control group comprised 3,240 carefully matched 'healthy' individuals.

They found that the amount of sick leave taken among long-term cancer survivors was significantly higher compared to controls for all five years after diagnosis. A total of 75 percent of the long-term cancer survivors took sick leave within the first 12 months after their diagnosis. Over the following four years, 23 percent of men and 31 percent of women recovering from cancer took sick leave, compared to approximately 18 percent of men and 27 percent of women in the control group.

Interestingly, socio-demographic factors were more important predictors of sick leave than the type or severity of the cancer. Being single with children, having low education, working in the health and social care sector, or having taken sick leave the year before diagnosis predicted sick leave taken five years after diagnosis.

The authors conclude: "Employed long-term cancer survivors may struggle with health impairments or reduced work ability five years after diagnosis. A socioeconomic and work environmental perspective seems necessary for occupational rehabilitation and the health and safety of , in order to reduce the rate of sick leave in this group."

Explore further: Cancer survivors have lower employment rates and work fewer hours

More information: Torp S et al (2012). Sick leave patterns among 5-year cancer survivors: a registry-based retrospective cohort study. Journal of Cancer Survivorship; DOI 10.1007/s11764-012-0228-8

Related Stories

Cancer survivors have lower employment rates and work fewer hours

June 22, 2011
Cancer survivors are less likely to be employed, and they work fewer hours, than similarly aged adults without a history of cancer, even two to six years after diagnosis, according to a study by Penn State researchers.

Sexual orientation affects cancer survivorship

May 9, 2011
Gay men have a higher prevalence of cancer compared with heterosexual men, and lesbian and bisexual female cancer survivors report lower levels of health than heterosexual female cancer survivors. Those are the conclusions ...

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.